Department of Postgraduate Medicine, Hertfordshire, University of Hertfordshire, U.K.
Department of Renal Research, Stevenage, East and North Hertfordshire NHS Trust, U.K.
Biosci Rep. 2019 Apr 12;39(4). doi: 10.1042/BSR20181704. Print 2019 Apr 30.
The gastrointestinal tract is a potential source of inflammation in dialysis patients. studies suggest breakdown of the gut barrier in uraemia leading to increased intestinal permeability and it is hypothesised that haemodialysis exacerbates this problem due to mesenteric ischaemia induced by blood volume changes during treatment.
The effect of haemodialysis on intestinal permeability was studied in ten haemodialysis patients and compared with five controls. Intestinal permeability was assessed by measuring the differential absorption of four orally administered sugar probes which provides an index of small and whole bowel permeability. A multi-sugar solution (containing lactulose, rhamnose, sucralose and erythritol) was orally administered after an overnight fast. Plasma levels of all sugar probes were measured hourly for 10 h post-administration. In haemodialysis patients, the procedure was carried out twice - once on a non-dialysis day and once immediately after haemodialysis.
Area under curve (AUC) for lactulose:rhamnose (L:R) ratio and sucralose:erythritol (S:E) ratio was similar post-dialysis and on non-dialysis days. AUC for L:R was higher in haemodialysis patients compared with controls (0.071 vs. 0.034, =0.001), AUC for S:E ratio was not significantly different. Levels of lactulose, sucralose and erythritol were elevated and retained longer in haemodialysis patients compared with controls due to dependence of sugars on kidney function for clearance.
We found no significant acute changes in intestinal permeability in relation to the haemodialysis procedure. Valid comparison of intestinal permeability between controls and haemodialysis patients was not possible due to the strong influence of kidney function on sugar levels.
胃肠道是透析患者炎症的潜在来源。研究表明,尿毒症导致肠道屏障破裂,导致肠道通透性增加,并且假设血液透析会通过治疗过程中血液量变化引起的肠系膜缺血加重这个问题。
本研究在 10 名血液透析患者中研究了血液透析对肠道通透性的影响,并与 5 名对照者进行了比较。通过测量四种口服糖探针的差异吸收来评估肠道通透性,这提供了小肠和全肠通透性的指数。在禁食过夜后,口服给予多糖溶液(包含乳果糖、鼠李糖、三氯蔗糖和赤藓糖醇)。给药后 10 小时内每小时测量所有糖探针的血浆水平。在血液透析患者中,该程序在非透析日和血液透析后立即进行两次。
透析后和非透析日,乳果糖:鼠李糖(L:R)比值和三氯蔗糖:赤藓糖醇(S:E)比值的曲线下面积(AUC)相似。血液透析患者的 L:R AUC 高于对照组(0.071 对 0.034,=0.001),S:E 比值的 AUC 无显著差异。由于糖的清除依赖于肾功能,乳果糖、三氯蔗糖和赤藓糖醇的水平在血液透析患者中升高并保留时间更长。
我们没有发现与血液透析过程相关的肠道通透性的急性显著变化。由于肾功能对糖水平的强烈影响,无法在对照组和血液透析患者之间进行肠道通透性的有效比较。